Article
HOPX homeobox methylation in differentiated thyroid cancer and its clinical relevance
26 Oct 2018
Abstract excerpt
BACKGROUND: The inactivation of the tumor-suppressor homeodomain-only protein X (HOPX) usually involves promoter methylation in several cancer types. This study aimed to investigate the HOPX-β mRNA expression and promoter methylation and their clinical relevance in differentiated thyroid cancer (DTC). PATIENTS AND METHODS: Clinicopathological data and paraffin-embedded thyroid tumor tissues from 21 patients with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
